These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 7839179

  • 21. Difficulties in diagnosis and management of bipolar disorder: three case presentations.
    Brady KT.
    J Clin Psychiatry; 2000; 61 Supp 13():32-7. PubMed ID: 11153810
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Selective response to the anticonvulsant carbamazepine in manic-depressive illness: a case study.
    Post RM, Berrettini W, Uhde TW, Kellner C.
    J Clin Psychopharmacol; 1984 Aug; 4(4):178-85. PubMed ID: 6432857
    [Abstract] [Full Text] [Related]

  • 24. Treatments for late-life bipolar disorder.
    Aziz R, Lorberg B, Tampi RR.
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature.
    Ketter TA, Pazzaglia PJ, Post RM.
    J Clin Psychopharmacol; 1992 Aug; 12(4):276-81. PubMed ID: 1527232
    [Abstract] [Full Text] [Related]

  • 28. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK.
    J Clin Psychiatry; 2003 Aug; 64 Suppl 5():18-24. PubMed ID: 12720480
    [Abstract] [Full Text] [Related]

  • 29. [Drug combinations of lithium: reasons and limitations].
    Lagomarsino AJ.
    Acta Psiquiatr Psicol Am Lat; 1993 Dec; 39(4):319-25. PubMed ID: 8191909
    [Abstract] [Full Text] [Related]

  • 30. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G.
    J Clin Psychiatry; 1999 Dec; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Anticonvulsants in the treatment of bipolar disorder.
    Keck PE, McElroy SL, Nemeroff CB.
    J Neuropsychiatry Clin Neurosci; 1992 Dec; 4(4):395-405. PubMed ID: 1422166
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Developments in mood stabilisers.
    Ferrier IN.
    Br Med Bull; 2001 Dec; 57():179-92. PubMed ID: 11719917
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Anticonvulsant therapy and suicide risk in affective disorders.
    Goodwin FK.
    J Clin Psychiatry; 1999 Dec; 60 Suppl 2():89-93; discussion 111-6. PubMed ID: 10073394
    [Abstract] [Full Text] [Related]

  • 38. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
    Li X, Ketter TA, Frye MA.
    J Affect Disord; 2002 May; 69(1-3):1-14. PubMed ID: 12103447
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.